General overview of the different types of pulmonary hypertension and the importance of identifying your PH type and other factors to develop a treatment plan. Learn about setting treatment goals and the various components of treatment including medical and other approaches that play a role in managing PH. Christopher King provides an overview of the standard approach to treating pulmonary arterial hypertension using pulmonary vasodilator medications and the different targeted pathways – endothelin, nitric oxide, prostacyclin, and activin signaling. He explains combination therapies as a part of developing a treatment plan. Watch the series of videos to learn more about pulmonary vasodilator medications and each of the targeted pathways.

Speaker

Christopher King, MD, FCCP
Associate Medical Director, Advanced Lung Disease and Transplant Program
PFF Center Director
Associate Medical Director, PAH and CTEPH Program
System Director, Respiratory Care Services